Latest News

DocuSign stock plunges 30% as pandemic boom appears to dissipate


DocuSign Inc. shares plummeted nearly 30% in after-hours trading Thursday, after the company’s billings and revenue forecast missed expectations and its chief executive admitted a pandemic boom wore off in the quarter.


easily topped third-quarter expectations with its earnings report Thursday afternoon, but the company’s billings — which reflect future business under contract — and fourth-quarter forecast came in lighter than expected. In a statement, the electronic-signature company’s chief executive said the immense growth experienced during the COVID-19 pandemic appeared to be dissipating.

“After six quarters of accelerated growth, we saw customers return to more normalized buying patterns, resulting in 28% year-over-year billings growth,” CEO Don Springer said in Thursday’s announcement.

DocuSign shares dove more than 25% to prices that would be a 52-week low in the extended session, a move that would wipe away more than $10 billion in market capitalization if it maintains through Friday’s trading session. DocuSign was worth less than $20 billion when the pandemic began, but spiked beginning in April 2020 to a market cap of more than $40 billion as businesses sought to complete deals without the ability to sign documents in person.

Subscribe: Want intel on all the news moving markets? Sign up for our daily Need to Know newsletter.

DocuSign reported a third-quarter loss of $5.7 million, or 3 cents a share, on sales of $545.5 million, up from $382.9 million a year ago. After adjusting for stock-based compensation and other effects, the company reported earnings of 58 cents a share, up from 22 cents a share a year ago. Analysts on average expected adjusted earnings of 46 cents a share on sales of $532.6 million, according to FactSet, a bar that DocuSign easily cleared.

However, the company reported billings of $565.2 million, short of its own guidance for $585 million to $597 million as well as analysts’ average forecast of $594 million. For the fourth quarter, management guided for revenue of $557 million to $563 million and billings of $647 million to $659 million, while analysts on average were projecting sales of $575 million and billings of $705.4 million, according to FactSet.

After spiking early in the pandemic, DocuSign shares had already leveled off in 2021, gaining 5.2% so far this year as the S&P 500 index

added 20.2%.

What to expect from the stock market in 2022, according to leading forecast models

Previous article

Morgan Stanley Pounds the Table on NIO Stock

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News